Founded 2017
Founders Michael Dove, CEO, Inoviv Ernestas Sirka, CSO, Inoviv

Inoviv matches patients with the right drugs. We develop blood tests for major diseases to work out which patients will respond to drugs. Our unique technology, based on targeted proteomics, measures hundreds of molecules in the blood at a fraction of the cost of competitor tests, meaning we can develop tests where others cannot.


Founders

Michael
Dove

CEO, Inoviv

Worked in consulting and business development at top pharmaceutical and healthcare organisations

Ernestas
Sirka

CSO, Inoviv

Leading researcher in proteomics and clinical test development

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.